Cite Filings / RNAC / 0001213900-20-033067
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Cartesian Therapeutics, Inc. · Filed 2020-10-23 · Acc 0001213900-20-033067

Documents 1

  • SC 13D/A Beneficial Ownership Report , ea128848-13da6spring_select.htm

Around this filing

  • 2021-05-27 SC 13D/A Beneficial Ownership Report
  • 2020-10-27 4 Chief Scientific Officer acquired 30,000 shares (option exercise)
  • 2020-10-23 4 Director bought 3,644,692 shares at an average $2.62 ($9,555,907)
  • 2020-10-23 SC 13D/A Beneficial Ownership Report
  • 2020-10-20 4 Director bought 1,887,696 shares at an average $2.30 ($4,336,230)
  • 2020-10-15 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading ea128848-13da6spring_select.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…